Evaluation of pulsed and breath-synchronized nebulization of budesonide as a means of reducing nebulizer wastage of drug

Pediatric Pulmonology

Volumn 29, Issue 2, 2000, Pages 120-126

  Nikander, Kurt ^a,b   Turpeinen, M ^c   Wollmer, P ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adults; Asthma; Breath synchronization; Budesonide; Children; Nebulization; Pulsed jet nebulization; Randomized controlled clinical trial

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ARTICLE; ASTHMA; BREATHING PATTERN; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NEBULIZATION; NEBULIZER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE;

ADOLESCENT; ADULT; AEROSOLS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; RESPIRATION;

EID: 0033964521     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(200002)29:2<120::AID-PPUL6>3.0.CO;2-D     Document Type: Article

References (17)

1. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998;11:113-125.
2. Nikander K, Bisgaard H. The impact of constant and breath-synchronized nebulization on the inhaled mass of nebulized budesonide in infants and children. Pediatr Pulmonol 1999;28:187-193.
3. Clay MM, Clarke SW. Wastage of drug from nebulisers: a review. J Roy Soc Med 1987;80:38-39.
4. Nikander, K. Drug nebulization systems. J Aerosol Med [Suppl] 1994;7:19-24.
5. Coates AL, Ho SL. Drug administration by jet nebulization. Pediatr Pulmonol 1998;26:412-423.
6. Pelkonen AS, Nikander K, Turpeinen M. Jet nebulization of budesonide suspension into a neonatal ventilator circuit: synchronized vs. continuous flow. Pediatr Pulmonol 1997;24:282-286.
7. Rosenthal RR. Inhalation challenge. NER Allergy Proc 1988;9: 113-119.
8. Nieminen MM, Holli H, Lahdensuo A, Muittari A, Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis 1987;71:145-152.
9. Mitchell JP, Nagel MW, Archer A. The nebulization of budesonide suspension via small volume nebulizers: a comparative in vitro assessment. Chest [Suppl] 1998;114:295.
10. United States Patent, patent number 5,687,912.
11. Nikander K. Adaptive aerosol nebulization: the principles. Eur Respir Rev 1997;7:385-387.
12. Denyer J. Adaptive aerosol nebulization in practise. Eur Respir Rev 1997;7:388-389.
13. Stick S. Measurements during tidal breathing. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: Wiley-Liss, Inc.; 1996. P 134.
14. Lodrup Carlsen KC, Nikander K, Carlsen K-H. How much nebulised budesonide reaches infants and toddlers? Arch Dis Child 1992;67:1077-1079.
15. Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulized budesonide in preschool children. Arch Dis Child 1999;80:241-247.
16. Chua HL, Collis GG, Newbury AM, Chan K, Bower GD, Sly PD, LeSouef PN. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7:2185-2191.
17. Nerbrink O, Ekelius C. Investigation of the pulse from two different commercial dosimeters. J Aerosol Med 1997;10:272 [abstract].